Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity

Immunology Letters

Volumn 129, Issue 1, 2010, Pages 7-12

  Shah, Dilip ^a   Kiran, Ravi ^a   Wanchu, Ajay ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Erythematosus (SLE); Interferon (IFN) ; Interleukin (IL) 12; Oxidative stress; Systemic lupus

Indexed keywords

CATALASE; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 12; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSATE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INDIAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL;

ADULT; CATALASE; CELL EXTRACTS; CELLS, CULTURED; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; GLUTATHIONE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TH1 CELLS;

EID: 77649184355     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.01.005     Document Type: Article

References (42)

1. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxf.) 41 (2002) 1095-1100
2. Kurien B.T., and Scofield R.H. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 73 (2003) 1655-1666
3. Taysi S., Gul M., Sari R.A., Akcay F., and Bakan N. Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40 (2002) 684-688
4. Lourenco E.V., and La Cava A. Cytokines in systemic lupus erythematosus. Curr Mol Med 9 (2009) 242-254
5. Grondal G., Gunnarsson I., Ronnelid J., Rogberg S., Klareskog L., and Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 18 (2000) 565-570
6. Avalos I., Chung C.P., Oeser A., Milne G.L., Morrow J.D., Gebretsadik T., et al. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16 (2007) 195-200
7. Ahsan H., Ali A., and Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131 (2003) 398-404
8. Mansour R.B., Lassoued S., Gargouri B., El Gaid A., Attia H., and Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 37 (2008) 103-108
9. Kurien B.T., and Scofield R.H. Lipid peroxidation in systemic lupus erythematosus. Indian J Exp Biol 44 (2006) 349-356
10. Turgay M., Durak I., Erten S., Ertugrul E., Devrim E., Avci A., et al. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J Rheumatol 10 (2007) 101-106
11. Turi S., Nemeth I., Torkos A., Saghy L., Varga I., Matkovics B., et al. Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22 (1997) 161-168
12. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., and Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390 (2009) 191-214
13. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 95 (1998) 3071-3076
14. Perl A., Gergely Jr. P., and Banki K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int Rev Immunol 23 (2004) 293-313
15. McKnight A.J., Zimmer G.J., Forgelman I., Wolf S.F., and Abbas A.K. Effect of IL-12 on the helper T cell dependent immune responses in vivo. J Immunol 152 (1994) 2172-2179
16. Bertagnolli M.M., Lin B.Y., Young D., and Herrmann S.H. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 149 (1992) 3778-3783
17. Chang D.M., Su W.L., and Chu S.J. The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunol Invest 31 (2002) 1-12
18. Viallard J.F., Pellegrin J.L., Ranchin V., Schaeverbeke T., Dehais J., Longy-Boursier M., et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115 (1999) 189-195
19. Liu T.F., and Jones B.M. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 10 (1998) 140-147
20. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
21. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35 (1992) 630-640
22. Lohr G.W., and Waller H.D. Glucose-6-phosphate dehydrogenase. Methods Enz Anal 2 (1974) 636-643
23. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
24. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186 (1978) 189-195
25. Luck H. Catalase. In: Bergmeyer Hu (Ed). Methods of enzymatic analysis vol. III (1971), Academic Press, New York 279
26. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
27. Beutler E., Duron O., and Kelly B.M. Improved method for the determination of blood glutathione. J Lab Clin Med 61 (1963) 882-888
28. Lowry O.H., Rosenborogh N.J., Farr A.L., and Randell R.J. Protein measurement with folin phenol reagent. J Biol Chem 193 (1971) 265-275
29. Morgan P.E., Sturgess A.D., and Davies M.J. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 43 (2009) 117-127
30. Cimen M.Y., Cimen O.B., Kacmaz M., Ozturk H.S., Yorgancioglu R., and Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19 (2000) 275-277
31. Tewthanom K., Janwityanuchit S., Totemchockchyakarn K., and Panomvana D. Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center. J Pharm Pharm Sci 11 (2008) 30-34
32. Crane F.L., and Low H. Reactive oxygen species generation at the plasma membrane for antibody control. Autoimmune Rev 7 (2008) 518-522
33. Winterbourn C.C., and Stern A. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 80 (1987) 1486-1491
34. D'souza A., Kurien B.T., Rodgers R., Shenoi J., Kurono S., Matsumoto H., et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 9 (2008) 62
35. Murata Y., Shimamura T., and Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 14 (2002) 201-212
36. Perricone C., Carolis C.D., and Perricone R. Glutathione: a key player in autoimmunity. Autoimmune Rev 8 (2009) 697-701
37. Horwitz D.A., Gray J.D., Behrendsen S.C., Kubin M., Rengaraju M., Ohtsuka K., et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41 (1998) 838-844
38. Akahoshi M., Nakashima H., Tanaka Y., Kohsaka T., Nagano S., Ohgami E., et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42 (1999) 1644-1648
39. Theofilopululos A.N., Koundouris S., Kono D.H., and Lawson B.R. The role of IFN-γ in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 3 (2001) 136-141
40. Harigai M., Kawamoto M., Hara M., Kubota T., Kamatani N., and Miyasaka N. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol 181 (2008) 2211-2219
41. Tucci M., Lombardi L., Richards H.B., Dammacco F., and Silvestris F. Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol 154 (2008) 247-254
42. Ortona E., Margutti P., Franconi F., and Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmune Rev 7 (2008) 579-584